Mondelez International, Inc. · NASDAQ:MDLZ

Mondelez International — Investor Presentation (August 2021)

23 slides from Mondelez International's investor presentation, August 2021

  1. Slide 1: Vaccine Education Series Session V

    SESSION V * iiotectedprogetticd Mondelez International © SNACKING MADE RIGHT

  2. Slide 2: Our Agenda Today: Vaccine Education Series

    OUR AGENDA TODAY VACCINE EDUCATION SERIES 1) THE DELTA VARIANT & THE VACCINE @) VACCINE SAFETY & EFFICACY © BOOSTERS & OTHER UPDATES © axa we” Protected Togethet

  3. Slide 3: Speaker introduction

    MD MPH is the Director of infectious diseases research and Professor of Pediatrics at University of Missouri, Kansas City. She is a frequent commentator on U.S. media networks and in media outlets.

  4. Slide 4: Our Agenda Today: Vaccine Education Series

    OUR AGENDA TODAY LS TACCINE EDUCATION SERIES 1) THE DELTA VARIANT & THE VACCINE @) VACCINE SAFETY & EFFICACY © BOOSTERS & OTHER UPDATES © wa re Protected Togethet

  5. Slide 5: Unvaccinated people allow stronger mutations such as Delta

    As long as people remain unvaccinated, the virus continues to create new and stronger more aggressive mutations, such as Delta variant.

  6. Slide 6: Delta variant spreads more quickly

    • Spreads more quickly than earlier versions of the virus —it’s as contagious as chickenpox, and more contagious than the flu or the common cold. People infected with Delta likely have more virus in their system and can spread that virus over a longer period of time than with previous variants. • Fu

  7. Slide 7: Mask guidance outdoors and indoors

    ▪ You don’t need to wear a mask outdoors if you’re not in a crowd and have adequate social distancing from people whose vaccination status is unknown ▪ Consider wearing a mask if COVID cases in your community are high ▪ Attending outdoor packed events is considered high risk, so it is highly recomme

  8. Slide 8: Our Agenda Today: Vaccine Education Series

    OUR AGENDA TODAY LS TACCINE EDUCATION SERIES 1) THE DELTA VARIANT & THE VACCINE @ VACCINE SAFETY & EFFICACY © BOOSTERS & OTHER UPDATES © wa “eo Protected Together

  9. Slide 9: 2) Vaccine Safety

    2) VACCINE SAFETY a YACEME EDOCATION SERIES 4.48 BILLION DOSES HAVE BEEN ADMINISTERED WORLDWIDE & 352 MILLION IN THE U.S. UNDER THE MOST INTENSE VACCINE SAFETY MONITORING IN HISTORY

  10. Slide 10: Vaccine effectiveness by vaccine and outcome

    ...and real life 80-95% 42-79% O, 33-88% S, 96% H 76% O No public data 33% S, 92 %H ~33% S, 71% H, 96% D O= Overall, S= Symptomatic, H= Hospitalization, D=Death

  11. Slide 11: Vaccine Efficacy

    2 VACCINE EFFICACY Efficacy against symptomatic infection England Scotland Israel Canada 100 Alpha Delta Alpha Delta. Alpha Delta Alpha Delta Vaccine: — Pfizer/BioNTech =. ae — Astrazeneca 80 = Number of doses: @---One 60 @—— Two 20 Lo} Alpha Delta ~ Alpha Delta ~~ Alpha Delta ~~ Alpha Delta Alpha D

  12. Slide 12: Breakthrough infections explained

    ▪ A breakthrough infection is when a fully vaccinated person (2 weeks after second dose) becomes infected and experiences illness. For such people, the vaccine still provides them strong protection against serious illness and death. ▪ Breakthrough cases are rare (1.1% of the vaccinated) and more lik

  13. Slide 13: Breakthrough hospitalizations and deaths

    “Breakthrough” infections in fully vaccinated people accounted for fewer than 1,200 of more than 107,000 COVID-19 hospitalizations (that’s about 1.1%) About 150 of the more than 18,000 COVID-19 deaths in May were in fully vaccinated people (that’s about 0.8%)

  14. Slide 14: Our Agenda Today: Vaccine Education Series

    OUR AGENDA TODAY LS TACCINE EDUCATION SERIES 1) THE DELTA VARIANT & THE VACCINE @) VACCINE SAFETY & EFFICACY @© BOOSTERS & OTHER UPDATES © wa ve Protected Togethet

  15. Slide 15: Booster doses

    ▪ COVID-19 vaccine boosters might not be necessary for most people, and could divert much-needed doses away from others ▪ WHO has called for halting COVID-19 vaccine boosters in favor of unvaccinated ▪ The F.D.A. is aiming to speed extra vaccine doses for immunocompromised patients ▪ Concerns over w

  16. Slide 16: Mixed-dose vaccination

    ▪ Flexibility in allowing mixed- dose vaccination might help people get fully vaccinated faster ▪ Mixing two different vaccines could actually do a better job of protecting against COVID-19 than sticking to the same one for all doses

  17. Slide 17: COVID-19 cases among children

    ▪ Surge in COVID-19 cases among kids, and increased hospitalizations ▪ 15% of COVID cases now are children ▪ Children under 12 probably won’t be eligible for vaccination until well into the fall or winter ▪ Families with children under age 12 who are still not eligible for vaccination or living with

  18. Slide 18: 3) Important Updates

    3) IMPORTANT UPDATES ae AINE EDUCATION SERED FULL FDA APPROVAL OF THE PFIZER-BIONTECH VACCINE IS EXPECTED BY EARLY SEPTEMBER! PEDIATRIC DATA FOR 5-11 YEAR OLDS BEING SUBMITTED TO THE FDA THIS FALL Wai

  19. Slide 19: Experts are clear: vaccines work

    (6 VACCINE EDUCATION SERIES EXPERTS ARE CLEAR: VACCINES WORK! SAFE AND EFFECTIVE VACCINES ARE THE BEST SOLUTION TO THE PANDEMIC 4 a Protected Together

  20. Slide 20: Open Q&A Session

    4 OPEN Q&A SESSION VACCINE EDUCATION SERIES WHAT'S ON YOUR MIND?

  21. Slide 21: Protect yourself, your families, your colleagues

    PROTECT YOURSELF. PROTECT YOUR FAMILIES. PROTECT YOUR COLLEAGUES. WE'RE STRONGER TOGETHER!

  22. Slide 22: Vaccine Education Series

    VACCINE EDUCATION SERIES 4ronger 2 Protected

  23. Slide 23: Up-to-date guidance and resources

    Up-to-date information on our guidance relating to COVID and vaccines can be found on our dedicated intranet page. ▪ Vaccine Info Session I Recording and Presentation (January) ▪ Vaccine Info Session II Recording and Presentation (February) ▪ Vaccine Info Session III Recording, Presentation and YouT

Mondelez International — Investor Presentation (August 2021) on 6ix